Drug maker seeks approval for use against multidrug-resistant tuberculosis
Makers of an investigational tuberculosis drug that has been urged for “compassionate use” approval in South Africa have applied to the European Medicines Agency to market the medicine as part of a...
View ArticleStudy reveals effective preventive dose, pain drug for tuberculosis...
New approaches to disease treatment and prevention, as well as failures in old approaches are part of what we’re reading this week . . . NIH-Funded analysis estimates effective PrEP dosing for men...
View ArticleTB drug trial yields gains in drug-resistant disease treatment
A study following patients who had participated in a trial of a potential new treatment for drug-resistant tuberculosis has shown heartening results, with nearly three-quarters of patients who took...
View ArticleWHO 2012 Global Tuberculosis Report shows uneven progress
New cases of TB have been falling for several years, while access to care has expanded, and deaths from tuberculosis have dropped by forty percent since the mid-1990s. That’s some of the progress...
View ArticleFDA panel finds new type of TB drug effective, raising hopes for treatment of...
Dr. Dalene von Delft had a choice between dying or going deaf, and that was a choice only if the arduous treatment she was undergoing for drug-resistant tuberculosis worked. The South African...
View ArticleFDA TB drug approval a milestone, with caveats
The U.S. Food and Drug Administration’s approval of the first new drug to treat tuberculosis in nearly half a century and the agency’s first use of its accelerated approval process to speed...
View ArticleTurn up the volume for an all-video edition of What We’re Reading . . .
Turn up the volume for these videos on issues that are often surrounded by silence: The reasons for rectal microbicides, the neglected world of children with tuberculosis, the health consequences of...
View ArticleUS TB drug shortages highlight global gaps
This is how small the world of infectious diseases can be, and how recent the distant past. The patient who ended up at Baltimore’s Health Department in April 2011 had been treated with apparent...
View ArticleTB Week: Survivors and allies recount illness, treatment, and loss
In the week leading up to International Tuberculosis Day, which commemorates the discovery by Robert Koch of the cause of the disease in 1882, Science Speaks will look at issues, events and efforts to...
View ArticleWHO guidance on first new TB treatment in five decades offers hope,...
WHO cites need to prevent new drug resistance, protect first treatment advance in more than 40 years The World Health Organization’s release this week of interim policy guidelines on the use of...
View Article$45 million TB cut will not affect “aggregate U.S. support,” Shah says
But doesn’t explain how . . . When USAID Administrator Dr. Rajiv Shah went to Congress to discuss the Obama administration’s budget proposal for fiscal year 2015, he began with remarks in which he...
View ArticleAIDS 2014: HIV and tuberculosis are one disease in Southern Africa
Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the coming week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE,...
View ArticleIDWeek: Update TB strategies to meet global challenges
PHILADELPHIA, PA- Without new tools, soon, to address multidrug-resistant tuberculosis, TB control efforts made over the last two decades will be defeated, Dr. Carol Dukes Hamilton said this week, in...
View ArticleIn stories of Ebola survivors, of MDR TB and poverty, of employment and HIV...
“It never occurred to me I was going to survive . . .” In a video that is part of a West African multimedia campaign highlighting Ebola survivor’s stories to disseminate information about the virus...
View ArticleTB Elimination: India can Lead the Way
Categories: HIV/TB Co-infection, TBTags: HIV/TB coinfection, Multidrug-resistant tuberculosis, tuberculsosisAs the United Nations High Level Meeting on HIV/AIDS gets underway today in New York, Indian...
View ArticleFindings indicate two newest TB drugs, bedaquiline and delamanid in...
A study following outcomes of 28 patients with drug-resistant tuberculosis in three countries with high burdens of the disease found what the researchers cite as strong evidence that a combination of...
View ArticleWhat we’re reading: Saying goodbye to gay sex bans, providing safe injection,...
In the midst of stalled funding and politicized policies, we’re reading about answers to infectious diseases that remain just out of reach . . . Inspired by India, Singaporeans seek to end gay sex ban...
View Article
